Literature DB >> 3700456

Carcinogenicity of small doses of inhaled N-nitrosoacetoxymethyl-N-methylamine in Syrian golden hamsters.

R G Klein, P Schmezer, D Komitowski.   

Abstract

Male Syrian golden hamsters inhaled 0.5-1 ppm (= 2.7-5.5 mg/m3) of N-nitroso-N-acetoxy-methyl-N-methylamine 1 h/week, for 14 weeks. The total dose per animal was calculated as 150-400 micrograms or 1-3 mg/kg. Four squamous cell carcinomas and one mucoepidermoid carcinoma of the nasal mucosa were observed. No such tumors occurred in the control group.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3700456     DOI: 10.1007/bf00400746

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  5 in total

1.  Natural history of intestinal neoplasms induced in rats by a single injection of methyl(acetoxymethyl)nitrosamine.

Authors:  J M Ward; J M Rice; P P Roller; M L Wenk
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

2.  [On the carcinogenic action of N-nitroso-compounds. 5th Communication: acetoxymethyl-methyl-nitrosamine (author's transl)].

Authors:  M Wiessler; D Schmähl
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-01-02

3.  Carcinogenicity of N-nitroso-acetoxymethyl-methylamine (acetoxymethyl-methylnitrosamine) after inhalation in rats.

Authors:  R G Klein
Journal:  Toxicology       Date:  1983-06       Impact factor: 4.221

4.  Chemotherapeutic studies on N-nitrosoacetoxymethyl-methylamine-and 1,2-dimethylhydrazine-induced colonic tumors in rats: monotherapy with 5-fluorouracil, ftorafur, CGP 6809, and CGP 15'720A.

Authors:  I Wagner; M Habs; D Schmähl; H Amberger; U Bachmann
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

5.  Carcinogenicity of acetoxymethyl-methyl-nitrosamine after subcutaneous, intravenous and intrarectal applications in rats.

Authors:  M Habs; D Schmähl; M Wiessler
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-05-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.